[CANMEDLIB] TI Methods Speaker Series: Do we need journal peer review? Changes between 121 epidemiology preprints & subsequent journal publications

Salzwedel, Douglas douglas.salzwedel at ubc.ca
Tue Jul 27 00:14:34 EDT 2021


*apologies for cross-posting*

 

Therapeutics Initiative Methods Speaker Series: Do we need journal peer review? Changes between 121 epidemiology preprints and their subsequent journal publications 

WHEN: Wednesday, August 25, 2021 from 12:00-13:00 PDT [convert to your local time: https://bit.ly/2WdOU15 <https://bit.ly/2WdOU15>]

WHERE: Offered online using Zoom. You must register order to receive the Zoom link.

SPEAKER: Dr. Mario Malički MD, PhD, Stanford University

REGISTRATION: bit.ly/2US6lnF <applewebdata://8159354B-3EEB-4440-B395-9438285B34A4/bit.ly/2US6lnF>
 

About the topic: Till 31 December 2019 there were 1,538 epidemiology preprints posted on bioRxiv. On January 5 2021, 844 (55%) of those were subsequently published as journal articles. We analysed 121 pairs of these preprints and their article versions (of record). These 121 were published in 73 different journals (of median IF 4), with a median time of 204 days following the posting of the preprint. Half of preprints were posted before or at the same time as being submitted to journals. Out of the 121 pairs, 26% had differences in their titles, 5% in the number or order of authors, 44% in their section subtitles (e.g., IMRaD), 84% in the number of references, 26% in the number of tables, 23% in the number of figures, 44% in acknowledgment sections, 61% in conflicts of interest sections, 59% in limitations sections of discussion, and 18% in the first sentence they used to describe their (main) results in the discussion section. In this talk we will discuss these and dozen more changes we analysed, and we will focus on inciting a debate on whether any of these changes could be considered “significant” in regards to the studies design, analysis or results, or were they more cosmetic or reporting in their nature.

About the speaker: After finishing School of Medicine at the University of Zagreb, Croatia, Dr. Mario Malički obtained an MA in Literature and Medicine at King’s College, London, UK, and then worked at the University of Split School of Medicine in Departments of Medical Humanities and Research in biomedicine and health, where he obtained a PhD in Medical Ethics titled: Integrity of scientific publications in biomedicine. Dr. Malički has been researching authorship, peer review, duplicate publications, and publication bias. From 2017-2019 he was a postdoc at AMC and ASUS Amsterdam, Netherlands, and in 2020 he joined METRICS (https://metrics.stanford.edu/ <https://metrics.stanford.edu/>) at Stanford University where he focuses on meta-research of preprints. Dr. Malički is the Co-Editor-in-Chief of Research Integrity and Peer Review journal https://researchintegrityjournal.biomedcentral.com <https://researchintegrityjournal.biomedcentral.com/>
About the Therapeutics Initiative <https://www.ti.ubc.ca/> Methods Speaker Series: TI Methods Speaker Series webinars are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. The presentations are recorded and the video recordings are posted online. Click here <https://www.ti.ubc.ca/2020/11/25/methods-speaker-series-2021/> to view the scheduled topics for 2021 and click here <https://www.ti.ubc.ca/2019/12/20/methods-speaker-series-2020/> to view a list of TI Methods Speaker Series talks offered in 2020.

 



Best wishes,
Doug

---

Douglas M Salzwedel  MLIS
Information Specialist & Assistant Managing Editor
Cochrane Hypertension




E douglas.salzwedel at ubc.ca <mailto:douglas.salzwedel at ubc.ca>   M +1 778 668 1862   S Doug.Salzwedel   T DougSalzwedel
University of British Columbia, 300C - 2176 Health Sciences Mall, Vancouver (Canada)
hypertension.cochrane.org <http://hypertension.cochrane.org/>

Trusted evidence. Informed decisions.Better health.

I acknowledge that I work on the traditional, ancestral, and unceded territory of the xwməθkwəy̓əm (Musqueam, Skwxwú7mesh (Squamish), Stó:lō and Səl̓ílwətaʔ/Selilwitulh (Tsleil- Waututh) Nations




-------------- next part --------------
An HTML attachment was scrubbed...
URL: </pipermail/canmedlib-chlaabsc.koumbit.org/attachments/20210727/e46221bb/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: HTN.png
Type: image/png
Size: 14464 bytes
Desc: not available
URL: </pipermail/canmedlib-chlaabsc.koumbit.org/attachments/20210727/e46221bb/attachment-0001.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: smime.p7s
Type: application/pkcs7-signature
Size: 1493 bytes
Desc: not available
URL: </pipermail/canmedlib-chlaabsc.koumbit.org/attachments/20210727/e46221bb/attachment-0001.bin>


More information about the CANMEDLIB mailing list